132 related articles for article (PubMed ID: 37301536)
1. FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.
Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
[TBL] [Abstract][Full Text] [Related]
2. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
[TBL] [Abstract][Full Text] [Related]
4. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
[TBL] [Abstract][Full Text] [Related]
5. Fbxo22 promotes cervical cancer progression via targeting p57
Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
[TBL] [Abstract][Full Text] [Related]
6. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
Johmura Y; Harris AS; Ohta T; Nakanishi M
Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008
[TBL] [Abstract][Full Text] [Related]
7. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
[TBL] [Abstract][Full Text] [Related]
8. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
9. FBXO22, ubiquitination degradation of PHLPP1, ameliorates rotenone induced neurotoxicity by activating AKT pathway.
Zheng X; Yu S; Xue Y; Yan F
Toxicol Lett; 2021 Oct; 350():1-9. PubMed ID: 34182063
[TBL] [Abstract][Full Text] [Related]
10. SCF
Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
[TBL] [Abstract][Full Text] [Related]
11. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
[TBL] [Abstract][Full Text] [Related]
12. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.
Dikopoltsev E; Foltyn VN; Zehl M; Jensen ON; Mori H; Radzishevsky I; Wolosker H
J Biol Chem; 2014 Dec; 289(49):33904-15. PubMed ID: 25336657
[TBL] [Abstract][Full Text] [Related]
13. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation.
Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.
De S; Holvey-Bates EG; Mahen K; Willard B; Stark GR
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795058
[TBL] [Abstract][Full Text] [Related]
15. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
[TBL] [Abstract][Full Text] [Related]
16. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.
Jiang J; Bai J; Qin T; Wang Z; Han L
J Cell Mol Med; 2020 May; 24(10):5901-5910. PubMed ID: 32294802
[TBL] [Abstract][Full Text] [Related]
17. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
[TBL] [Abstract][Full Text] [Related]
18. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis.
Suzuki N; Johmura Y; Wang TW; Migita T; Wu W; Noguchi R; Yamaguchi K; Furukawa Y; Nakamura S; Miyoshi I; Yoshimori T; Ohta T; Nakanishi M
Autophagy; 2021 Nov; 17(11):3776-3793. PubMed ID: 33706682
[TBL] [Abstract][Full Text] [Related]
19. FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
Li S; Shi L; Wang Y; Zhang L; Chu S; Li M; Bai J; Zhu W
Exp Cell Res; 2023 Sep; 430(1):113719. PubMed ID: 37442264
[TBL] [Abstract][Full Text] [Related]
20. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
